The submission to WHO was based on the companies’ previous regulatory submission to the Drugs Controller General of India (DCGI). Biotech company Novavax and vaccine maker Serum Institute of India (SII) have applied to the World Health Organisation (WHO) for an emergency use listing (EUL) for the Novavax Covid-19 vaccine. Novavax and SII made regulatory … Read more
SII has got exclusive rights for the vaccine in India and non-exclusive rights during the pandemic period in all countries excluding upper-middle/high-income countries. Serum Institute of India (SII) and US biotechnology company Novavax on Friday applied for emergency use authorisation to the Drugs Controller General of India to launch Covid-19 vaccine Covovax in India. Novavax … Read more
India is vaccinating on an average 50 lakh individuals daily since June 21, equivalent to inoculating the entire population of Norway every day, the Centre said on Friday and asserted that the process is like a “marathon and not a 100-metre race”. Addressing a press briefing, Lav Agarwal, Joint Secretary, health ministry, said till date, … Read more
The government had placed the order for 40 million Pfizer vaccines and only half of it is expected to arrive in the fourth quarter of this year. Change in vaccination guidelines pertaining to AstraZeneca vaccine appears to have impacted the inoculation drive within the country. In the recent changes made by the Australian government, the … Read more
Serum is making the Sputnik V dose, which happens to be the second dose, the other is the first dose. (Reuters image) Pune-based Serum Institute of India (SII), which has been the largest producer of vaccines in India, making the Oxford-AstraZeneca vaccine Covishield – hopes to begin manufacture of two more vaccines – Corovax (made … Read more
A group of developing countries, backed by United Nations agencies and activist groups, is pushing to limit patent protections for Covid-19 vaccines being tested by some of the world’s biggest pharmaceutical companies so that inexpensive copies can be produced for poorer nations. South Africa, Ghana, Senegal, Pakistan and others argue they won’t be able to … Read more